USD 12.38
(2.31%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 2.22 Billion USD | 27.28% |
2022 | 1.74 Billion USD | 0.21% |
2021 | 1.74 Billion USD | -4.45% |
2020 | 1.82 Billion USD | -35.54% |
2019 | 2.83 Billion USD | 27.45% |
2018 | 2.22 Billion USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 2.21 Billion USD | -0.5% |
2024 Q1 | 2.22 Billion USD | 0.04% |
2024 Q3 | 2.33 Billion USD | -0.12% |
2023 Q4 | 2.22 Billion USD | 0.04% |
2023 Q2 | 2.22 Billion USD | -0.02% |
2023 Q1 | 2.22 Billion USD | 27.2% |
2023 Q3 | 2.22 Billion USD | 0.04% |
2023 FY | 2.22 Billion USD | 27.28% |
2022 Q3 | 1.82 Billion USD | -0.2% |
2022 FY | 1.74 Billion USD | 0.21% |
2022 Q4 | 1.74 Billion USD | -4.2% |
2022 Q2 | 1.82 Billion USD | 0.64% |
2022 Q1 | 1.81 Billion USD | 4.13% |
2021 Q3 | 1.81 Billion USD | -4.87% |
2021 Q4 | 1.74 Billion USD | -3.99% |
2021 FY | 1.74 Billion USD | -4.45% |
2021 Q1 | 1.83 Billion USD | 0.7% |
2021 Q2 | 1.9 Billion USD | 3.88% |
2020 Q2 | 2.86 Billion USD | 0.0% |
2020 FY | 1.82 Billion USD | -35.54% |
2020 Q3 | 2.95 Billion USD | 3.41% |
2020 Q4 | 1.82 Billion USD | -38.34% |
2020 Q1 | - USD | -100.0% |
2019 Q1 | - USD | 0.0% |
2019 FY | 2.83 Billion USD | 27.45% |
2019 Q4 | 2.83 Billion USD | 0.0% |
2018 FY | 2.22 Billion USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Aclaris Therapeutics, Inc. | 3.07 Million USD | -72238.126% |
Applied DNA Sciences, Inc. | 739.16 Thousand USD | -300737.164% |
Aspira Women's Health Inc. | 1.43 Million USD | -155401.678% |
Biodesix, Inc. | 35.22 Million USD | -6212.772% |
BioNexus Gene Lab Corp. | 98.76 Thousand USD | -2251425.369% |
bioAffinity Technologies, Inc. | 1.11 Million USD | -198714.271% |
bioAffinity Technologies, Inc. | 1.11 Million USD | -198714.271% |
Bionano Genomics, Inc. | 7.17 Million USD | -30891.972% |
CareDx, Inc | 28.27 Million USD | -7763.618% |
Check-Cap Ltd. | - USD | -Infinity% |
Castle Biosciences, Inc. | 14.19 Million USD | -15561.882% |
DarioHealth Corp. | 24.59 Million USD | -8942.633% |
Exact Sciences Corporation | 2.47 Billion USD | 10.167% |
Fulgent Genetics, Inc. | 10.11 Million USD | -21892.622% |
Guardant Health, Inc. | 1.13 Billion USD | -95.065% |
ICON Public Limited Company | 3.66 Billion USD | 39.334% |
IDEXX Laboratories, Inc. | 622.88 Million USD | -256.997% |
Illumina, Inc. | 1.48 Billion USD | -49.34% |
Intelligent Bio Solutions Inc. | 81.32 Thousand USD | -2734239.186% |
iSpecimen Inc. | 29.13 Thousand USD | -7633521.696% |
Standard BioTools Inc. | 3.98 Million USD | -55729.124% |
MDxHealth SA | 35.56 Million USD | -6152.598% |
23andMe Holding Co. | 67.84 Million USD | -3177.58% |
Medpace Holdings, Inc. | 142.12 Million USD | -1464.623% |
Myriad Genetics, Inc. | 130.9 Million USD | -1598.758% |
Mainz Biomed B.V. | 2.19 Million USD | -101165.319% |
ENDRA Life Sciences Inc. | 192.06 Thousand USD | -1157689.672% |
NeoGenomics, Inc. | 606.06 Million USD | -266.901% |
Neogen Corporation | 888.39 Million USD | -150.304% |
Inotiv, Inc. | 399.4 Million USD | -456.741% |
Natera, Inc. | 282.94 Million USD | -685.903% |
OPKO Health, Inc. | 222.03 Million USD | -901.502% |
Psychemedics Corporation | 945 Thousand USD | -235209.418% |
Prenetics Global Limited | 867.21 Thousand USD | -256315.537% |
Prenetics Global Limited | 867.21 Thousand USD | -256315.537% |
Precipio, Inc. | 106 Thousand USD | -2097705.66% |
Personalis, Inc. | 1.23 Million USD | -180100.486% |
RadNet, Inc. | 812.06 Million USD | -173.829% |
Sera Prognostics, Inc. | 840 Thousand USD | -264623.095% |
Neuronetics, Inc. | 59.28 Million USD | -3650.947% |
Star Equity Holdings, Inc. | 1.14 Million USD | -194107.336% |
Star Equity Holdings, Inc. | 1.14 Million USD | -194107.336% |
Trinity Biotech plc | 54.65 Million USD | -3968.862% |
Twist Bioscience Corporation | 79.17 Million USD | -2708.627% |
Exagen Inc. | 19.23 Million USD | -11462.966% |